GW Pharmaceuticals PLC Reported Fourth Quarter Financial Results

GW Pharmaceuticals (NASDAQ: GWPH) announced fourth quarter financial results.  “We are proud to have recently launched Epidiolex, the first and only FDA-approved plant-derived cannabinoid medicine and a much needed new treatment option for patients with LGS and Dravet syndrome, two of the most difficult-to-treat forms of childhood-onset epilepsy. We are pleased with both the response of the medical community to the product launch and with the coverage decisions made to date by insurance providers, and we are committed to ensuring that appropriate patients can access treatment,” stated Justin Gover, GW’s Chief Executive Officer. “We also announced positive results from an additional Phase 3 trial in Dravet syndrome, further reinforcing the potential for Epidiolex to produce clinically meaningful seizure reductions in this patient population. The recent U.S. launch of Epidiolex introduces a new chapter for GW as a commercial-stage company and reinforces our world leadership in cannabinoid science. We fully expect to maintain this leadership as we leverage the potential of our cannabinoid product pipeline to meet unmet needs of patients across a range of therapeutic areas.”

Cash and cash equivalents at September 30, 2018 were $354.9 million compared to $322.2 million as of September 30, 2017 Revenue for the year ended September 30, 2018 was $12.7 million compared to $8.6 million for the year ended September 30, 2017 Net loss for the year ended September 30, 2018 was $295.2 million compared to $170.5 million for the year ended September 30, 2017 October equity financing resulted in net proceeds of $324.2 million

  1. Todd Harrison 4 years ago

    I’ve owned this at various levels of exposure from $36 to $180 and back; still think $350 => $500 as other indications come thru pipe but $GWPH moves at it’s own pace, always has, and decidedly NOT promotional, which rubs this immediate-gratification mkt the wrong way. /position

  2. Lawrence Dubois 4 years ago


  3. Shawn Provencher 4 years ago

    $GWPH is still my favorite Medical Cannabis Pharmaceutical. #long

Leave a Comment